article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Key senators make a big pivot on bipartisan insulin cost proposal

STAT News

WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.) Jeanne Shaheen (D-N.H.) Read the rest…

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tjoapack and Biopharma: Our Packaging Options

Pharma Packaging Solutions

Biopharma Packaging from Tjoapack Biopharmaceutical technology is advancing every day as scientists work to create new, better treatments for diseases that millions struggle with on a daily basis. With biologic treatments becoming ever more available, the need for smart, reliable biopharma packaging is on the rise.

article thumbnail

Understanding the role of recombinant insulin in cell culture systems: What the studies say 

Pharmaceutical Technology

Among several growth-promoting supplements added to the cell culture media formulations, insulin is one of the most common. Recombinant insulin is used as a supplement in the upstream manufacturing of a range of biologic drugs, including recombinant proteins, such as monoclonal antibodies, viral vectors, and viruses.

Insulin 130
article thumbnail

What Are Biopharmaceuticals?

Pharma Packaging Solutions

Biopharmaceuticals, also called biologics, are drug products that are manufactured using biological sources. Hormones (such as insulin, glucagon, and growth hormone, to name a few) are produced by recombinant DNA, as are blood factors, thrombolytic agents, interferons, monoclonal antibodies, therapeutic enzymes, and more.

article thumbnail

Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics

XTalks

In 2022, Januvia was flagged for nitrosamine contamination , a potential carcinogen commonly produced as a byproduct during drug manufacturing. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6

Sales 52
article thumbnail

Provention Bio Launches Campaigns for Familial Type 1 Diabetes Screening

XTalks

Autoantibody screening involves measuring levels of islet autoantibodies (iAb) that recognize antigens found in insulin-producing pancreatic beta cells. Provention will conclude the filing upon submission of its manufacturing package this quarter.

Insulin 98